Cell-mediated and humoral immunity during COVID-19 in the Republic of Crimea
Journal: Acta Biomedica Scientifica (East Siberian Biomedical Journal)
Year: 2023

The COVID-19 (coronavirus disease 2019) pandemic has spurred the development of highly effective quantitative methods for assessing the adaptive immune response to the SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus 2) virus. In order to assess the humoral component of the immune response, various methods for detecting immunoglobulins A, M, G are widely used. ELISPOT seems to be the most accessible and effective method to assess the level of T cells that specifically respond to